title: Early prosthetic valve endocarditis complicating repeated attempts at CoreValve implantation.
abstract: Transcatheter aortic valve implantation is emerging as a promising, effective therapy for high-risk patients not eligible to undergo surgical aortic valve replacement. Infection complications have only rarely been reported. We report a case of probable endocarditis caused by coagulase-negative Staphylococcus following repeated attempts at implantation of a CoreValve bioprosthesis.
authors.affiliation: 4 Erithrou Stavrou Street and Kifissias Avenue, Marousi, Athens, Greece. mchrissoheris@hotmail.com
authors.forename: Michael P
authors.initials: MP
authors.lastname: Chrissoheris
authors.forename: Angeliki
authors.initials: A
authors.lastname: Ferti
authors.forename: Konstantinos
authors.initials: K
authors.lastname: Spargias
mesh_terms: D000369:Aged, 80 and over; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000601:surgery*; D001705:Bioprosthesis / Q000009:adverse effects / Q000382:microbiology; D006328:Cardiac Catheterization; D017548:Echocardiography, Transesophageal; D004696:Endocarditis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis / Q000009:adverse effects* / Q000382:microbiology; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D012086:Reoperation / Q000009:adverse effects*; D013203:Staphylococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D013212:Staphylococcus epidermidis / Q000302:isolation & purification
chemical_list: D000900:Anti-Bacterial Agents